Core Viewpoint - Chemed Corporation will present at the Jefferies 2025 Healthcare Services Conference on September 30, 2025, at 1:50 p.m. (CT) [1] Company Information - The presentation will take place at the 1 Hotel in Nashville [1] - The event will be webcast live, and materials will be accessible on the Chemed website [1] - A replay of the webcast will be available within 24 hours after the live presentation [1]

NASHVILLE, Tenn.--(BUSINESS WIRE)--TailorCare, a leading provider of value-based specialty care solutions for musculoskeletal (MSK) health, today announced plans to expand its partnership with Humana Inc. (NYSE: HUM) into Dallas and Denver. Humana Medicare Advantage (MA) members who qualify for these programs will now have access to TailorCare's personalized, evidence-based MSK navigation and care coordination support. Currently serving Humana members in Atlanta, TailorCare advances quality of. ...

Core Insights - McKesson has raised its fiscal 2026 adjusted EPS guidance range to $38.05-$38.55 from a previous range of $37.10-$37.90, exceeding the consensus estimate of $37.48 [2] - Following the announcement, McKesson's shares increased by 1.72% in pre-market trading, reaching $709.00 [2] - The company is scheduled to host its 2025 Investor Day today [2]

Core Insights - NextPlat Corp's ClearMetrx subsidiary is developing ClearMetrX 4.0, an AI-enhanced healthcare data analytics software, expected to launch internally in Q4 2025 and commercially in H1 2026 [1][2]. Company Overview - NextPlat Corp is a global consumer products and services company that provides healthcare and technology solutions through e-Commerce and retail channels [5]. Product Development - ClearMetrX 4.0 will feature AI-powered enhancements aimed at improving healthcare data collection, analysis, and operationalization, thereby supporting better patient outcomes and adherence [2][3]. - The software will include capabilities such as revenue forecasting, predictive inventory management, anomaly detection, audit assistance, fraud detection, and what-if simulations [6]. Market Context - The global AI in healthcare market was valued at approximately USD 26.57 billion in 2024 and is projected to grow to USD 187.69 billion by 2030, with a CAGR of 38.62% from 2025 to 2030, driven by the demand for efficiency and accuracy in healthcare [2].

Core Viewpoint - Ardent Health has successfully amended and extended its $777.5 million Term Loan Facility, resulting in a reduced interest rate and extended maturity [1] Financial Summary - The applicable interest rate has been reduced by 50 basis points from Term Secured Overnight Financing Rate (SOFR) plus 2.75% to Term SOFR plus 2.25% [1] - The maturity of the facility has been extended to September 2032 [1]

Group 1 - Strive will acquire Semler Scientific in an all-stock deal valued at approximately $1.34 billion, expanding its cryptocurrency holdings [1] - Semler shareholders will receive 21.04 Class A common shares of Strive for each Semler share, valuing Semler at $90.52 per share, representing a premium of over 210% compared to its previous closing price [1] - The acquisition follows Strive's recent merger with Asset Entities as part of its strategy to list on Nasdaq and focus on buying and holding bitcoin [2] Group 2 - Strive plans to purchase 5,816 bitcoin for a total of $675 million, resulting in the combined company owning more than 10,900 bitcoin [2] - The deal indicates a growing trend of corporate adoption of bitcoin treasury strategies, similar to the approach initiated by Michael Saylor in 2020 [4] - Bitcoin has increased by 20.5% this year, outperforming the S&P 500's 13.3% rise, aided by regulatory developments that have improved the relationship between cryptocurrency and traditional finance [4]

Premier Inc. (NASDAQ:PINC) said Monday it will be acquired by an affiliate of Patient Square Capital in a deal valued at $28.25 per share in cash. The agreement, unanimously approved by Premier’s board, gives shareholders a 23.8% premium to the company’s 60-day average closing price as of Sept. 5, 2025. Board chair Richard Statuto said the sale will provide “immediate and certain value” to investors while giving the company more capital to expand services during a pivotal moment in U.S. health care. Also ...

Core Insights - The Experian Health 2025 State of Claims survey highlights increasing challenges faced by healthcare providers [1] Group 1 - The survey indicates that healthcare providers are experiencing growing difficulties in managing claims [1] - Key issues identified include rising operational costs and complexities in the claims process [1] - The findings suggest a need for improved strategies to address these challenges in the healthcare sector [1]

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Name: Sandeep Dadlani Previous title: Executive vice president and chief digital and technology officer, UnitedHealth New title: CEO, Optum Insight Dadlani started as chief executive of Optum Insight last week, the executive announced in a LinkedIn post saying he’s “honored and privileged” to step into the role. Dadlani first joined UnitedHealth in 2022 as the ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Nutex Health Inc. due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by October 21, 2025 [4][10]. Group 1: Allegations Against Nutex - The complaint alleges that Nutex and its executives made false or misleading statements and failed to disclose critical information regarding their financial practices and internal controls [6]. - Specific allegations include that Nutex engaged in a fraudulent scheme with HaloMD to defraud insurance companies, leading to unsustainable revenue [6]. - The company is accused of overstating its ability to remediate weaknesses in its financial reporting controls, which resulted in improper accounting for stock-based compensation [6]. Group 2: Stock Price Impact - Following the release of a short report by Blue Orca Capital, Nutex's stock price fell by $11.18 per share, or 10.05%, closing at $100.01 on July 22, 2025 [8]. - After Nutex announced a delay in filing its Form 10-Q due to accounting adjustments, its stock price dropped further by $18.22 per share, or 16.39%, closing at $92.91 on August 15, 2025 [9]. Group 3: Legal and Investor Actions - Investors who suffered losses exceeding $50,000 between August 8, 2024, and August 15, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal options [1]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Nutex's conduct [11].